AL
Alfresa Holdings Corporation
ALFRY · OTC
$13.55 +0.00% (+$0.00)
Market Cap ¥388.9B
P/E Ratio 9.74x
Div. Yield 3.23%
ROE 8.08%
Bulios Fair Price
$15.11
11.5% upside
Current Price
$13.55
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALFRY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/S 0.12x
P/E 9.74x
P/B 0.81x
Growth
32 /100
Declining Book val. growth 0.72%
EPS growth 1.33%
Rev. growth 4.62%
Profitability
6 /100
Weak Op. margin 1.11%
Gross margin 6.98%
FCF margin 0.00%
Quality
39 /100
Average ROA 2.66%
ROIC 4.33%
Asset turnover 2.13x
Debt
93 /100
Low Int. coverage 97.57x
Debt/Equity 0.06x
Net debt/EBITDA -3.07x
Stability
84 /100
Stable EPS volatility 19.33%
Beta -0.16x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALFRY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Ryuji Arakawa
Employees
12,525
Headquarters
Tokyo